Medication info
Barostatin Tablet 20 mg (Atorvastatin Calcium Trihydrate)

Barostatin Tablet 20 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Trihydrate›21.7mg / 1 tablet
Manufacturer / importer
Sami Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201502712 · Approved 2015.04.30 · Insurance code 644003640

Summary

Main use
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular diseases (e.g., myocardial infarction)
Who uses it
Adults · Children
Adult dosage
Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Children's dosage
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or more.

Ingredients

Manufacturer
Sami Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular diseases (e.g., myocardial infarction)

  • Myocardial infarction
  • stroke
  • vascular surgery
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication is used to reduce the risk of myocardial infarction, stroke, the need for vascular surgery, angina, and hospitalization for heart failure in adults with various risk factors for cardiovascular disease, and in patients with type 2 diabetes. Additionally, it helps lower total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels, and increase HDL cholesterol levels, serving as an adjunct to diet in patients with hyperlipidemia. It is particularly effective in patients with primary dyslipidemia, familial hypercholesterolemia, and mixed dyslipidemia. It is also used to manage cholesterol levels in children aged 10 to 17 years with heterozygous familial hypercholesterolemia. This drug plays a critical role in reducing cardiovascular disease risk and improving blood lipid status.

Dosage and Administration

Adult dosage

Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.

Children's dosage

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or more.

Precautions

This medication may cause symptoms related to muscle abnormalities, so if severe muscle pain or weakness occurs, or if creatine kinase levels rise significantly, you should stop taking it immediately and consult your doctor. This medication should not be taken by patients with certain liver diseases, severely impaired liver function, women who are pregnant or may become pregnant, nursing women, children under 10 years old, or anyone allergic to any component of this drug. Patients with a history of liver disease or those who consume a lot of alcohol, patients with impaired kidney function, those with hypothyroidism, and the elderly should use this drug more cautiously under the supervision of a doctor. This medication may affect liver function, so regular liver function tests should be performed before and during usage, and if symptoms of hepatitis (nausea, vomiting, fatigue, etc.) develop, you should inform your doctor immediately. Use of this medication is prohibited during pregnancy, so women of childbearing age should ensure appropriate contraception while taking it, and discontinue use immediately if pregnancy is confirmed. This medication may interact with several other drugs, so if you are taking other medications, be sure to inform your doctor or pharmacist and use with caution. If symptoms such as muscle pain, fatigue, or fever occur while taking this drug, you should inform healthcare professionals immediately, and in severe cases, treatment may need to be stopped. Children, the elderly, and patients with impaired kidney function are at higher risk for muscle-related adverse reactions when taking this medication, so special caution is necessary. In the event of overdose, there is no specific antidote, so treatment should be symptomatic, and liver function and muscle-related tests should be conducted. This medication should be stored out of reach of children and kept in its original container to prevent misuse or deterioration in quality.

Side effects

  • Fatigue
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 153 more
  • decreased appetite
  • constipation
  • abdominal bloating
  • indigestion
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • perceptual disturbances
  • sensory loss
  • dysgeusia
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • polymorphous erythema
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • increased ACTH
  • decreased aldosterone
  • elevated potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • erectile dysfunction
  • urinary tract infection
  • frequency of urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • vasomotor edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • changes in corneal shape
  • loss of taste
  • dysgeusia
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • sweating
  • eczema
  • seborrhea
  • skin ulcer
  • sweating
  • eczema
  • seborrhea
  • skin ulcer
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • myasthenia gravis
  • ocular myasthenia
  • muscular weakness
  • muscle tone
  • muscle weakness
  • immune-mediated necrotizing myopathy
  • muscle symptoms
  • muscle pain
  • muscle tone
  • muscle weakness
  • acute hepatitis
  • hepatitis
  • liver dysfunction
  • jaundice
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • polymorphous erythema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This way, the efficacy and safety of the drug can be preserved for a long time.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.